Sale!

Lenvalieva 4MG

LENVATINIB

MRP	:	~~MRP ₹4,593.75~~
Price	:	₹2,100.00
You Save	:	₹2,493.75 (54.29%)

30 Capsule(s) In A Bottle

SKU: 1373 Categories: Anti-Cancer, Anti-Cancer Drugs Tag: ANTI CANCER DRUGS Brand: Allieva Pharma Pvt. Ltd.

Lenvalieva 4mg Capsule contains the active ingredient Lenvatinib. This medication is a tyrosine kinase inhibitor used for progressive or advanced thyroid cancer when radioactive iodine therapy is ineffective. Additionally, it is prescribed for liver cancer patients who have not received prior treatment and are not candidates for surgical intervention.

Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) typically manifests in individuals over 60 years old. Symptoms include an enlarged and hardened thyroid gland, along with voice hoarseness resulting from nerve paralysis in the larynx. Hepatocellular carcinoma (liver cancer) arises from existing liver issues such as cirrhosis or chronic hepatitis B infection. Individuals with a history of allergic reactions to Lenvalieva 4mg Capsule or any of its ingredients should avoid this medication. It is important for patients to notify their dentist or oral surgeon about their use of Lenvalieva 4mg Capsule, as it may hinder wound healing and elevate the risk of bleeding.

Certain types of advanced thyroid cancer
Advanced Liver cancer
Certain types of kidney cancer
Endometrial cancer

Lenvalieva 4mg Capsule inhibits the enzyme receptor tyrosine kinases (RTKs). These RTKs are responsible for the formation of new blood vessels that deliver oxygen and nutrients to cells, promoting their growth. This medication blocks the receptors that support the development of blood vessels in tumor cells. RTKs are found in elevated levels in cancer cells, and the use of this medicine reduces the speed at which cancer cells grow and multiply.

Notify your healthcare provider of all medications you are currently taking, which includes prescription drugs, over-the-counter medicines, nutritional or vitamin supplements, and herbal products.

Some medications may interact with Lenvalieva 4mg Capsule, potentially diminishing its effectiveness and leading to unwanted side effects.

Lenvalieva 4mg Capsule is an oral medication typically taken once daily, around the same time each day, with or without food. It must be taken as directed by a physician or healthcare professional. These capsules should be swallowed whole with a glass of water. They must not be crushed, chewed, or opened, as this may alter the absorption of the medication and reduce its effectiveness. You should not take two doses at once to compensate for a missed dose.

Lenvalieva 4mg Capsule should be stored at room temperature, between 20°C to 25°C (68°F to 77°F).

Serious:

Liver toxicity or liver failure
Heart problems, such as heart attack
Hemorrhage (bleeding)
Blood clots
Poor wound healing
Kidney failure
Hypothyroidism
Skin reactions (rash or blisters)

Common:

Fatigue
Loss of appetite
Weight loss
Nausea and vomiting
Diarrhea
Stomach pain or discomfort
Hypertension (high blood pressure)
Headache
Joint pain or muscle pain
Changes in taste

If you are in close contact with your healthcare provider, make sure to report any concerns or side effects as soon as possible. During treatment, avoid becoming pregnant or breastfeeding. Patients are advised to use effective contraception while taking Lenvalieva 4mg Capsule and for at least two weeks after discontinuing the treatment. It is important to refrain from consuming grapefruits, as they can interfere with the absorption of this medication. Additionally, patients should apply sunscreen and wear protective clothing when outdoors to minimize the risk of sunburn or skin damage. Until you understand how this medication affects you, it is advisable to avoid strenuous activities or exercise. Maintaining a healthy and balanced diet during treatment is essential for supporting your overall health and well-being. By staying informed and actively participating in your treatment, you can help ensure the best possible outcomes and manage any potential risks or complications that may arise.

Fact Box of Lenvalieva 4MG

Molecule Name: Lenvatinib

Therapeutic Class: Anticancer

Pharmacological Class: Tyrosine kinase inhibitor

Indications:

Px Required

10 capsule(s) in a strip

CIPLA LTD

₹500.00MRP: ₹1,747.97

Lenvalieva 4MG

Fact Box of Lenvalieva 4MG

Disclaimer

ADLANTE 4MG

LENVAMED Capsules 4mg

LENTRIS 4MG

LENRIS 4MG

GLENVAS 4MG

LENTA 4MG

LENVAT 4MG

LENVA 4 MG CAPSULES

Lenvenib 4mg

Lenced 4 mg

LENVATOL 4

2000+ products

Secure Payment

Easy Return

Company

Speciality Drugs

More Info

Lenvalieva 4MG

Salt Composition

Allieva Pharma Pvt. Ltd.

Fact Box of Lenvalieva 4MG

Disclaimer

2000+ products

Secure Payment

Easy Return